JEFFREY WEINBERG to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications JEFFREY WEINBERG has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.115
-
Innovative uses of tumor necrosis factor alpha inhibitors. Dermatol Clin. 2010 Jul; 28(3):559-75.
Score: 0.039
-
Successful treatment of severe atopic dermatitis in a child and an adult with the T-cell modulator efalizumab. Arch Dermatol. 2006 May; 142(5):555-8.
Score: 0.029
-
Advances in therapy for psoriasis: an overview of infliximab, etanercept, efalizumab, alefacept, adalimumab, tazarotene, and pimecrolimus. Curr Pharm Des. 2005; 11(2):273-80.
Score: 0.027
-
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol. 2020 04 15; 22(4):539-549.
Score: 0.019